BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19154410)

  • 1. Identification of C2orf18, termed ANT2BP (ANT2-binding protein), as one of the key molecules involved in pancreatic carcinogenesis.
    Kashiwaya K; Hosokawa M; Eguchi H; Ohigashi H; Ishikawa O; Shinomura Y; Nakamura Y; Nakagawa H
    Cancer Sci; 2009 Mar; 100(3):457-64. PubMed ID: 19154410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel tumor marker REG4 detected in serum of patients with resectable pancreatic cancer and feasibility for antibody therapy targeting REG4.
    Takehara A; Eguchi H; Ohigashi H; Ishikawa O; Kasugai T; Hosokawa M; Katagiri T; Nakamura Y; Nakagawa H
    Cancer Sci; 2006 Nov; 97(11):1191-7. PubMed ID: 16918991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C12orf48, termed PARP-1 binding protein, enhances poly(ADP-ribose) polymerase-1 (PARP-1) activity and protects pancreatic cancer cells from DNA damage.
    Piao L; Nakagawa H; Ueda K; Chung S; Kashiwaya K; Eguchi H; Ohigashi H; Ishikawa O; Daigo Y; Matsuda K; Nakamura Y
    Genes Chromosomes Cancer; 2011 Jan; 50(1):13-24. PubMed ID: 20931645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EphA4 receptor, overexpressed in pancreatic ductal adenocarcinoma, promotes cancer cell growth.
    Iiizumi M; Hosokawa M; Takehara A; Chung S; Nakamura T; Katagiri T; Eguchi H; Ohigashi H; Ishikawa O; Nakamura Y; Nakagawa H
    Cancer Sci; 2006 Nov; 97(11):1211-6. PubMed ID: 16965393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100A14 promotes progression and gemcitabine resistance in pancreatic cancer.
    Zhu H; Gao W; Li X; Yu L; Luo D; Liu Y; Yu X
    Pancreatology; 2021 Apr; 21(3):589-598. PubMed ID: 33579599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KIAA1199/CEMIP/HYBID overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.
    Koga A; Sato N; Kohi S; Yabuki K; Cheng XB; Hisaoka M; Hirata K
    Pancreatology; 2017; 17(1):115-122. PubMed ID: 28012880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SCNrank: spectral clustering for network-based ranking to reveal potential drug targets and its application in pancreatic ductal adenocarcinoma.
    Liu E; Zhang ZZ; Cheng X; Liu X; Cheng L
    BMC Med Genomics; 2020 Apr; 13(Suppl 5):50. PubMed ID: 32241274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic regulation and role of metastasis suppressor genes in pancreatic ductal adenocarcinoma.
    Mardin WA; Haier J; Mees ST
    BMC Cancer; 2013 May; 13():264. PubMed ID: 23718921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of RAB6KIFL/KIF20A, a kinesin involved with membrane trafficking of discs large homologue 5, can attenuate growth of pancreatic cancer cell.
    Taniuchi K; Nakagawa H; Nakamura T; Eguchi H; Ohigashi H; Ishikawa O; Katagiri T; Nakamura Y
    Cancer Res; 2005 Jan; 65(1):105-12. PubMed ID: 15665285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EVI1 oncogene promotes KRAS pathway through suppression of microRNA-96 in pancreatic carcinogenesis.
    Tanaka M; Suzuki HI; Shibahara J; Kunita A; Isagawa T; Yoshimi A; Kurokawa M; Miyazono K; Aburatani H; Ishikawa S; Fukayama M
    Oncogene; 2014 May; 33(19):2454-63. PubMed ID: 23752186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in Mice.
    Jandaghi P; Najafabadi HS; Bauer AS; Papadakis AI; Fassan M; Hall A; Monast A; von Knebel Doeberitz M; Neoptolemos JP; Costello E; Greenhalf W; Scarpa A; Sipos B; Auld D; Lathrop M; Park M; Büchler MW; Strobel O; Hackert T; Giese NA; Zogopoulos G; Sangwan V; Huang S; Riazalhosseini Y; Hoheisel JD
    Gastroenterology; 2016 Dec; 151(6):1218-1231. PubMed ID: 27578530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the Wnt pathway-associated LncRNAs and genes involved in pancreatic carcinogenesis driven by Tp53 mutation.
    Wang Q; Jiang H; Ping C; Shen R; Liu T; Li J; Qian Y; Tang Y; Cheng S; Yao W; Wang L
    Pharm Res; 2015 Mar; 32(3):793-805. PubMed ID: 24469904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weighted gene co-expression network analysis reveals key genes involved in pancreatic ductal adenocarcinoma development.
    Giulietti M; Occhipinti G; Principato G; Piva F
    Cell Oncol (Dordr); 2016 Aug; 39(4):379-88. PubMed ID: 27240826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kif20a inhibition reduces migration and invasion of pancreatic cancer cells.
    Stangel D; Erkan M; Buchholz M; Gress T; Michalski C; Raulefs S; Friess H; Kleeff J
    J Surg Res; 2015 Jul; 197(1):91-100. PubMed ID: 25953216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of astrocyte elevated gene-1 (AEG-1) as a biomarker for aggressive pancreatic ductal adenocarcinoma.
    Huang Y; Ren GP; Xu C; Dong SF; Wang Y; Gan Y; Zhu L; Feng TY
    BMC Cancer; 2014 Jul; 14():479. PubMed ID: 24989027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma.
    Bhatti I; Lee A; James V; Hall RI; Lund JN; Tufarelli C; Lobo DN; Larvin M
    J Gastrointest Surg; 2011 Jan; 15(1):199-208. PubMed ID: 21088996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling of microdissected pancreatic ductal carcinomas using high-density DNA microarrays.
    Grützmann R; Pilarsky C; Ammerpohl O; Lüttges J; Böhme A; Sipos B; Foerder M; Alldinger I; Jahnke B; Schackert HK; Kalthoff H; Kremer B; Klöppel G; Saeger HD
    Neoplasia; 2004; 6(5):611-22. PubMed ID: 15548371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addiction of pancreatic cancer cells to zinc-finger transcription factor ZIC2.
    Inaguma S; Ito H; Riku M; Ikeda H; Kasai K
    Oncotarget; 2015 Sep; 6(29):28257-68. PubMed ID: 26318045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiles of microdissected pancreatic ductal adenocarcinoma.
    Grützmann R; Foerder M; Alldinger I; Staub E; Brümmendorf T; Röpcke S; Li X; Kristiansen G; Jesenofsky R; Sipos B; Löhr M; Lüttges J; Ockert D; Klöppel G; Saeger HD; Pilarsky C
    Virchows Arch; 2003 Oct; 443(4):508-17. PubMed ID: 12942322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.